The endocrine function of human testes explants [assessed by measuring testosterone and insulin-like factor 3 (INSL3)] was impacted by exposure of the human adult testis explants to BPA/BPA-A.
Introduction
Bisphenol A (BPA) (2,2-bis (4-hydroxyphenyl) propane; CAS no. 80 b5-7) is currently produced in huge quantities (Vandenberg et al., 2007) . The population may be exposed to BPA from fetal life to adulthood (Cobellis et al., 2009; Vandenberg et al., 2010; Braun and Hauser, 2011; Koch et al., 2012) . Many reports claim that it belongs to the growing list of so-called endocrine-disrupting chemicals (Beronius et al., 2010; Teeguarden and Hanson-Drury, 2013) . The decision of a number of regulatory agencies to ban BPA from food packaging has led to the gradual development of a number of bisphenol analogs (BPA-A) to replace BPA in several applications. Among them, bisphenol S (BPS), bisphenol F (BPF), bisphenol E (BPE), bisphenol B (BPB) and bisphenol A diglycidyl ether (BADGE) have replaced BPA for use in thermal receipt paper (Liao et al., 2012a) or epoxy resin products (Danzl et al., 2009) . BPA is known to migrate from packaging materials into foodstuffs (Muncke, 2009; Coulier et al., 2010; Deceuninck et al., 2014; Oldring et al., 2014; Sungur et al., 2014) . BPA and BPF have also been found in a high percentage of food samples tested. Canned foods contain the highest concentrations of bisphenols . Furthermore, BPA-A have been reported in various environmental matrices, including water, sediment and dust (Fromme et al., 2002; Song et al., 2012; Liao et al., 2012b; Lee et al., 2014) .
BPB, BPS, BPF, BPA and BPAF have been detected in urine samples from some individuals (Cunha and Fernandes, 2010; Yang et al., 2014) . BADGE and its hydrated derivatives were detected in human adipose fat samples .
We investigated here for the first time the direct effects of BPA and BPA-A substitutes on the physiology of the human adult testis using an organotypic culture model.
Materials and Methods

Ethics statement
Adult testes were obtained from prostate cancer patients who had no antiandrogen treatment or multiorgan donors (all donors considered mean age: 46.75; SEM: ± 4.65 years). The local ethics committee approved the protocol, and written informed consent was obtained from either donors or their next of kin (CCPPRB Rennes; authorization 05/39-566; Agence de la Biomédecine; authorization #PFS09-015).
The testis explant assay
The testes obtained from patients or donors were placed at 4°C and processed immediately. The observation by transillumination allowed us to ascertain that the testes displayed spermatogenesis (Roulet et al., 2006) . Four 3-mm 3 testis explants were placed onto a PET insert (Falcon Labware; Becton Dickinson, Lincoln Park, NJ, USA) at the interface of air in 1 ml of Dulbecco's Modified Eagle's Medium supplemented with antibiotics, 1 mM sodium pyruvate, 4 mM glutamine, 100 ng/ml of vitamin A, 200 ng/ml of vitamin E, 50 ng/ml of vitamin C, 10 μg/ml of insulin and 5 μg/ml of transferrin and with one IU/ml hCG for culture, in 12-well plates. For the exposure experiments the media contained either 0.1% dimethylsulfoxide (DMSO) as a control, or BPA, BPB, BPE, BPF, BPS or BADGE at different concentrations (purity > 99%; Sigma-Aldrich, Saint Quentin Fallavier, France, diluted in DMSO at a final concentration of 0.1%). Four wells (corresponding to the replicates performed for each independent experiment) were analyzed for each condition. The exposures lasted 24 and 48 h, with a total medium change at 24 h. Media were stored at −80°C. On the day of collection, three explants for each culture condition were collected at random, fixed in either neutral buffered 4% formaldehyde or Bouin's fixative and embedded in paraffin. Then they were sliced into 5.0 μm-thick sections, and stored at +4°C until immunostaining. The potential external (procedural) contamination induced by BPA present in the plastic or the medium was checked by measuring the amount of BPA before and after treatment by gas chromatography coupled to tandem mass spectrometry GC-MS/MS (limit of quantification = 3 × 10 −10 M; Deceuninck et al., 2014) . The expected BPA concentrations were consistent with the concentrations actually measured. BPA biotransformation was studied by high-performance liquid chromatography (HPLC) coupled to an online radioactivity detection system using [
3 H]-BPA as already described (Ben-Maamar et al., 2015) .
Immunostaining
Leydig cells were labeled with a rabbit primary antibody directed against the cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1) (1/250; Sigma-Aldrich), on formaldehyde-fixed tissue. The apoptotic cells were stained with the primary rabbit antibody directed against cleaved caspase-3 (1/100; Ozyme, France; Desdoits- Lethimonier et al., 2012) . Slides were scanned with a NanoZoomer slide scanner (Hamamatsu Photonics, France, at Plateforme H2P2, Biosit, Rennes, France). Caspase-3 positive cells were counted with ImageJ free software.
Hormone production
Testosterone was assayed in the media with a specific radioimmunoassay (RIA; Immunotech, Beckman Coulter, France). The intra-and inter-assay coefficients of variation were ≤8.6 and 11.9%, respectively. Control testis explants produced an average of 10.26, SEM ± 2.50 ng/ml/explant testosterone after 24 h of culture, and 8.47 ± 2.16 ng/ml/explant after 48 h. Insulin-like factor 3 (INSL3) production was measured by RIA (RK-035-27, Phoenix France). The intra-and inter-assay coefficients of variation were ≤15 and 7%, respectively, and the lower limit of detection was 20.17 pg/ml.
Control testis explants produced an average of 620 ± 103 pg/ml/explant INSL3 after 24 h of culture, and 446 ± 99 pg/ml/explant after 48 h. Inhibin B was assayed by ELISA (DSL-10-84100 Active, Beckman Coulter, France). The intra-and inter-assay coefficients of variation for serum samples were ≤5.6 and 7.6%, respectively. Control testis explants produced an average of 570.43 ± 53.2 pg/ml/explant inhibin B after 24 h of culture, and 529.44 ± 55 pg/ml/explant after 48 h.
Quantitative PCR
RNA was extracted from human testes and liver samples with a NucleoSpin RNA II kit (Macherey-Nagel, France). Total RNAs (250 ng) were reverse transcribed with the Iscript cDNA Synthesis Kit (Biorad; France). Quantitative PCR was performed with the iTaq Universal SYBR Green Supermix (Biorad, France) with a 2.5 μl cDNA template in a CFX384 Touch Real-Time PCR Detection System (Biorad). The following amplification program was used: an initial denaturation for 3 min at 95°C; 40 cycles of 10 s denaturation at 95°C; and 30 s at 62°C for annealing and extension. Dissociation curves were produced with a thermal melting profile performed after the last PCR cycle. To avoid amplification of contaminating genomic DNA, primer pairs were selected on two different exons (for genes studied, see Table I ). Basic leucine zipper and W2 domains 1 (BZW1) and GAPDH mRNA were used as internal controls for normalization. Results were calculated by the ΔΔCT method as n-fold differences in target gene expression with respect to the reference gene and the calibration sample.
Statistics
Data were analyzed with GraphPad prism v6.05 (GraphPad software, USA). Values are expressed as the mean ± SEM. Differences between BPA, BPA-A treated and the corresponding control were analyzed using the non-parametric Mann-Whitney test. Dose-response relationships were analyzed using a non-parametric Spearman correlation test, and slopes and P-values were indicated when significant.
Results
Biotransformation of BPA
Radio-HPLC analysis of the biotransformation of human testicular explants revealed that after 24 h of incubation with H 3 -BPA, regardless of dose, only parent BPA was recovered in either the medium or the testis extracts, indicating that no or very little biotransformation of BPA took place. We also demonstrate that the testes expressed mRNAs for the main enzymes necessary to biotransform BPA, specifically UDP glucuronosyltransferase two family, polypeptide B15 (UGT2B15), glucuronidase beta (GUSB), sulfotransferase family 1 A member 1 (SULT1A1), sulfotransferase family 1 A member 3 (SULT1A3) and steroid sulfatase (STS) (Fig. 1) . UGT2B15 mRNA was very weakly expressed in the testis compared with the liver (0.1%). The testicular mRNA levels of GusB, Sult1A1 and Sult1A3 reached 36.1, 16.4 and 27.2% of those in the liver, respectively. Sult1A3 and STS were expressed in about the same range in both the testis and the liver.
Histopathology
Neither BPA nor the BPA-A impaired the histology of the testis explants according to staining of cleaved caspase-3 (1.5 × 710 Quantitative RT-PCRs were performed on adult human liver and testes. Each bar represents the mean ± SEM of the fold-change in target gene expression relative to the BZW1 and GAPDH reference genes. Each point represents mRNAs from three different donors. BZW1, basic leucine zipper and W2 domains 1; UGT2B15, UDPglucuronosyltransferases family 2 member B15; GUSB, beta-glucuronidase; SULT1A1, sulfotransferase family 1A member 1; SULT1A3, sulfotransferase family 1A member 3; STS, steroid sulfatase (microsomal), isozyme S. %, quantity expressed in the testis compared to the liver.
positive caspase-3 cells/μm 2 in control explants; Fig. 2 ) and CYP11A1
(data not shown).
Testosterone
Testosterone levels decreased significantly and dose dependently after BPA exposure (β = −0.478, P = 0.00778 at 24 h and β = −0.399, P = 0.0291 at 48 h; Fig. 3 A and B) . BPA appeared most anti-androgenic at a dose of 10 −5 M, at both time periods measured (24 and 48 h; −28.7 and −39.2% compared to control, respectively). Similarly, as levels of BPE at 24 h and BPF at 48 h rose, testosterone production fell significantly (β = −0.424, P = 0.039 and β = −0.54, P = 0.00663, respectively, Fig. 3 C and F) . At 24 h, BPE induced a significant decrease at the highest dose (−37.4%, P = 0.028; Fig. 3 C) . The response to BPF was more sensitive, as a significant decrease in testosterone was observed at 10 −6 M after 24 h and at 10 −6 and 10 −5 M after 48 h of exposure ( Fig. 3E and F) . BPB significantly decreased testosterone levels at 10 −7 M after 24 h (−17%, P = 0.028; Fig. 3 G) and 48 h (−47%, P = 0.028; Fig. 3 H) . BADGE significantly decreased testosterone levels by 12.3% at 10 −9 M and 28.8% at 10 −7 M after 24 h and by 19.1% after 48 h of culture with 10 −8 M (Fig. 3I and J) .
The effects of BPS varied, with paradoxical trends at 24 and 48 h. At the 24-h collection, testosterone levels had increased significantly at 10 −6 M (+17.8%, P < 0.05), but was significantly inhibited at a 10 −8 M concentration at 48 h (−18.9%; P = 0.052). The increases at 24 h for concentrations of 10 −7 M and 10 −6 M were attenuated at 48 h (12 and 16.6%, respectively; Fig. 3 K and L) .
Insulin-like factor 3
BPA, BPB and BPS significantly increased INSL3 production by Leydig cells at a low doses: 10 −9 M for BPA and BPB after 24 h of exposure (Fig. 4 A and G), and 10 −9 and 10 −8 M after 48 h of BPS exposure (Fig. 4 J) . BPB tended to increase INSL3 levels consistently after 24 h and 48 h of treatment at 10 −6 and 10 −5 M. BADGE showed a significant dose-response capacity to increase INSL3 after 48 h of exposure; the highest dose yielded a significant increase of 31.5% (Fig. 4 L) . By contrast, the exposure to BPE dose dependently inhibited INSL3 levels ( Fig. 4 C and D) . After 48 h, a significant negative correlation was observed: as BPE increased, INSL3 levels decreased (β = −0.814, P < 0.0001; Fig. 4D ).
Inhibin B
Neither BPA nor any of the BPA-A significantly affected the production of inhibin B by Sertoli cells (Fig. 5) .
Discussion
Based on the use of an ex vivo culture system previously used to study the effects of phthalates (Desdoits-Lethimonier et al., 2012) and of several analgesics (Albert et al., 2013) , our data reveal that BPA and of BPA-A exhibit anti-androgenic properties in the adult human testis. The individual concentrations at which the effects on the Leydig cell hormones were observed varied according to the bisphenol studied, the duration of incubation, and the dose considered. Furthermore effects of BPA, BPB, BPS and BADGE (increases), as well as of BPE (decrease) were observed on INSL3 production. The highest levels of urinary BPA have been associated with elevated estrogen levels in men (Kim et al., 2014; Lassen et al., 2014) , as well as with elevated concentrations of serum LH and testosterone (Galloway et al., 2010; Lassen et al., 2014) . Urinary BPA levels in BPA-exposed workers, compared to non-exposed workers have also been associated with significantly higher risks of male sexual dysfunction (Li et al., 2010) , decreased semen quality (Li et al., 2011) and decreased androgen levels (Zhou et al., 2013) . It has also been shown that BADGE generates BPA endogenously in BADGE-exposed male workers and that their plasma FSH levels decrease as their BPA levels rise. Nonetheless, neither free testosterone nor LH levels are affected in these conditions (Hanaoka et al., 2002) . In male partners of pregnant women, urinary BPA levels have been inversely associated only with the free androgen index (testosterone/sex hormone-binding globulin; Mendiola et al., 2010) . In men attending fertility clinics, urinary BPA concentrations are associated with a decline in semen quality parameters (Meeker et al., 2010b; Knez et al., 2014) , and appear to influence inhibin B, FSH and the estradiol/testosterone ratio (Meeker et al., 2010a) . Overall, only few epidemiological studies have been performed on the possible link between BPA and the endocrine balance in men, while no clear pattern of endocrine disruption has been demonstrated. A global observation of the pattern of hormonal profiles obtained here indicates that BPA and BPA-A can generate non-monotonic dose-response relationships (NMDRs), a feature frequently associated with BPA action (for reviews : Vandenberg, 2014; Lagarde et al., 2015) . In the present study, quantified dose-dependent curves were only found for BPA, BPF and BPE. We did demonstrate that BPA and all the investigated BPA-A can exhibit anti-androgenic properties in the adult human testis, with the individual concentrations at which the bisphenols suppressed testosterone varying according to the bisphenol studied, duration of incubation and dose considered. BPA still displayed some anti-androgenic effects after 24 h of exposure, which is a likely a consequence of the very low expression of UGT2B15 in the testis, as shown here. This is consistent with the expression of human UGT isoforms in 23 human tissues evidenced by others (Ohno and Nakajin, 2009) . Like BPA, BPE significantly inhibited testosterone production at 10 −5 M and at a rate close to that of BPA (35.4% for BPE and 27.5%
for BPA) after 24 h of exposure. However, the effect of BPE was less persistent than that of BPA. As different enzymes are responsible for the hydroxylation of the different bisphenols (Schmidt et al., 2013) , BPE may be biotransformed more efficiently than BPA in the human testis. In our study, a lower concentration of BPF (10 −6 M) had an inhibitory dose effect on testosterone production. This BPA-A, which is not approved as a food contact material in the European Union (EU), has been detected in beverages and canned food samples Yang et al., 2014) . In commercial milk samples, BPF was the bisphenol detected most frequently, followed by BPA and BPB (Grumetto et al., 2013) . BADGE and BPS are approved as food contact materials in the EU. In our human culture system, of all bisphenols tested, BADGE was the one that significantly displayed it antiandrogenic properties at the lowest dose (10 −9 M), while BPS was pro-androgenic at 24 h and anti-androgenic at 48 h. Before this study, the anti-androgenic properties of BPA had been described in various animal experiments (Kawai et al., 2003; Kabuto et al., 2004; Tanaka et al., 2006) , in the human adrenocortical NCI-H295R cell line (Zhang et al., 2011) , and in human and rat microsomes . Like BPA, some BPA-A were also shown to display anti-androgenicity in the steroidogenic NCI-H295R cell line (Rosenmai et al., 2014; Goldinger et al., 2015) . BPA and BPE, in the range of concentrations used in the present study, had inhibitory effects on testosterone similar to those in the human testis. In contrast, BPF inhibited testosterone production only weakly in the NCI-H295R cell line, and inhibition by BPS was slight (Rosenmai et al., 2014; Goldinger et al., 2015) , consistent with the result in our system after 24 h of exposure. While BPB suppressed testosterone production here (at 10 −7 M at both 24 and 48 h), its anti-androgenicity was close to that of BPA in the NCI-H295R cell line (Rosenmai et al., 2014) . Further support for our findings comes from a study that used the mouse Leydig cell line, known as the MA-10 cell line (Roelofs et al., 2015) . The interindividual variations in the levels of INSL3, the other Leydig cell hormone investigated, were greater than those of testosterone, as generally observed (Ivell et al., 2013; Mazaud-Guittot et al., 2013) . This and the NMDR also often encountered with this hormone complicated the interpretation of our data. Nevertheless it appears that, in contrast to testosterone, the levels of INSL3 generally tended to increase in the presence of BPA and BPA-A. The exception was for BPE, which dose dependently reduced INSL3 levels after 48 h of exposure.
Our findings also indicate that inhibin B was not affected by exposure to BPA or its analogs. The epidemiological studies investigating a link between male BPA exposure and inhibin B levels are far from providing a clear picture. Urinary BPA was found to be inversely associated with inhibin B levels measured in the serum of the male partners in subfertile couples (Meeker et al., 2011) . Furthermore, male workers in the highest quartile of BPA measurements had lower inhibin B levels (Liu et al., 2015) . Nonetheless, no such correlation between BPA and inhibin B was observed among male partners of pregnant women (Mendiola et al., 2010) or in Chinese male workers exposed or not exposed to BPA in factories (Zhuang et al., 2015) .
The mean concentration of BPA in human biological fluids (blood, urine and saliva) is generally found to be in the 10 −9 M order of magnitude (for reviews : Calafat et al., 2008; Bushnik et al., 2010; Vandenberg et al., 2010; Andra et al., 2015) . Therefore, the dose of 10 −5 M of BPA, which was found to significantly inhibit testosterone here, was much higher than the concentrations recorded in the body fluids. The significant BPA-induced anti-androgenicity observed at 10 −5 M in adult human testes was consistent with that obtained with human fetal testes when cultured in the presence of trophic hormone (hCG or LH), which optimizes the organ's integrity (histology and hormone production) during the culture periods investigated both in terms of histology (BenMaamar et al., 2015) and hormone production (Ben-Maamar et al., 2015; Eladak et al., 2015) . The fact that BPA or BPA-A can impact the production of testosterone by the human fetal testis at doses lower than 10 −5 M only appeared in the absence of trophic hormones (N'Tumba-Byn et al., 2012; Ben-Maamar et al., 2015; Eladak et al., 2015) . According to the human exposure studies available on BPA-A, equivalent values to those of BPA were found in urine for BPS and BPF, at average levels of~10 −9 −10 −10 M, (Zhou et al., 2014) . BPB and BADGE were detected infrequently and their levels were around 10 −9 M (Cobellis et al., 2009; Cunha and Fernandes, 2010; Wang et al., 2012 Wang et al., , 2015 Asimakopoulos et al., 2014) . The significant BPA-Ainduced suppression of testosterone found here occurred for exposure at lower concentrations (generally 10 −6
-10 −8 M) than that observed for BPA. In any case, these lower active doses still represent higher doses than those found in the human body fluids. Whether or not the short time frame of our culture conditions, dictated by our concern to achieve optimal experimental conditions in terms of morphological quality of the explants, is an obstacle for demonstrating BPA/BPA-Ainduced anti-androgenic effects for doses close to those of human exposure is unknown. Whether the BADGE-induced anti-androgenic effect or the BPA and BPB-induced pro-INSL3 effects detected at 10 −9 M represents an intrinsic effect of these BP compounds or corresponds to an effect resulting from the mixture of BADGE or of BPA and BPB with the low levels of BPA contaminating the control culture media is not known.
To conclude, based on the available epidemiological evidence (Minguez-Alarcon et al., 2016) and the results of this series of experiments, further research is needed to clarify the actual risk of exposure to BPA and BPA-A on male and couple reproductive health.
